Retinal Research Institute is a clinical research site located in Phoenix, Arizona, United States 85017.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Retinal Research Institute has participated in 14 clinical trials with 2 currently active.
Therapeutic areas: Neovascular Age-Related Macular Degeneration, Geographic Atrophy, Age-related Macular Degeneration (AMD).
Sponsors: Graybug Vision, Apellis Pharmaceuticals, Inc., Regeneron Pharmaceuticals.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Retinal Research Institute has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Retinal Research Institute has 14 clinical trials on record, with 2 currently active. Their work covers Neovascular Age-Related Macular Degeneration, Geographic Atrophy, Age-related Macular Degeneration (AMD).
Yes — Retinal Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.